For episode 10 of the <a href='https://pharmaphorum.com/podcast'>pharmaphorum podcast</a> I spoke to Nicola Redfern, who’s general manager at bluebird bio in the UK.
The Cambridge, Massachusetts-based company has gone from being a gene therapy start-up to having three potential blockbusters on its books, with a CAR-T cancer medicine and potential treatments for a type of sickle-cell disease and a rare and deadly genetic brain disease.

For episode 10 of the pharmaphorum podcast I spoke to Nicola Redfern, who’s general manager at bluebird bio in the UK. The Cambridge, Massachusetts-based company has gone from being a gene therapy start-up to having three potential blockbusters on its books, with a CAR-T cancer medicine and potential treatments for a type of sickle-cell disease and a rare and deadly genetic brain disease.

For episode 10 of the <a href="https://pharmaphorum.com/podcast" rel="noopener noreferrer">pharmaphorum podcast</a> I spoke to Nicola Redfern, who’s general manager at bluebird bio in the UK.
The Cambridge, Massachusetts-based company has gone from being a gene therapy start-up to having three potential blockbusters on its books, with a CAR-T cancer medicine and potential treatments for a type of sickle-cell disease and a rare and deadly genetic brain disease.

Gene therapy and market access: the pharmaphorum podcast

pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.

Share Gene therapy and market access: the pharmaphorum podcast

Sign up to save your podcasts

Gene therapy and market access: the pharmaphorum podcast

Gene therapy and market access: the pharmaphorum podcast

More shows like pharmaphorum Podcast

Nature Podcast

The Daily

The Readout Loud

BioCentury This Week

The Mel Robbins Podcast